ilaria righi

Dr. ilaria righi


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Davide TosiDavide Tosi
Davide Tosi
AMAlessandra Mazzucco
Alessandra Mazzucco
VMValeria Musso
Valeria Musso
GBGianluca Bonitta
Gianluca Bonitta
LRLorenzo Rosso
Lorenzo Rosso
Alessandro PalleschiAlessandro Palleschi
Alessandro Palleschi
Video-assisted thoracic surgery (VATS) is a consolidated approach; however, there is no consensus on the number of ports leading to less postoperative pain. We compared early postoperative pain after uniportal and three-portal VATS lobectomy for early-stage NSCLC. In this randomized clinical trial, patients undergoing VATS lobectomy were randomly assigned to receive uniportal (U-VATS Group) or three-portal (T-VATS Group) VATS. The inclusion criteria were age ≤ 80 years and ASA < 4. The exclusion criteria were clinical T3, previous thoracic surgery, induction therapy, chest radiotherapy, connective tissue or vascular diseases, major organ failure, and analgesics or corticosteroids use. The postoperative analgesia protocol was based on NRS. Pain was measured as analgesic consumption; the secondary endpoints were intra- and postoperative complications, conversion rate, surgical time, dissected lymph nodes, hospital stay, and respiratory function. Out of 302 eligible patients, 120 were included; demographics were distributed homogeneously. The mean cumulative morphine consumption (CMC) in the U-VATS Group after 7 days was lower than in the T-VATS Group (77.4 mg vs. 90.1 mg, p = 0.003). Intraoperative variables and postoperative complications were comparable. The 30-day intercostal neuralgia rate was lower in the U-VATS Group, without reaching statistical significance. Patients undergoing U-VATS showed a lower analgesic consumption compared with the T-VATS Group; analgesic consumption was moderate in both groups.

17 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Eleonora TobaldiniEleonora Tobaldini
Eleonora Tobaldini
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
GMGiorgio Mantoan
Giorgio Mantoan
AMAlice Monti
Alice Monti
GZGiulia Coti Zelati
Giulia Coti Zelati
Francesco BlasiFrancesco Blasi
Francesco Blasi
Although the literature demonstrates that cardiac autonomic control (CAC) might be impaired in patients with chronic pulmonary diseases, the interplay between CAC and disease severity in end-stage lung disease has not been studied yet. We investigated the effects of end-stage lung disease on CAC through the analysis of heart rate variability (HRV) among patients awaiting lung transplantation. Forty-nine patients on the waiting list for lung transplantation (LTx; 19 men, age 38 ± 15 years) and 49 healthy non-smoking controls (HC; 22 men, age 40 ± 16 years) were enrolled in a case–control study at Policlinico Hospital in Milan, Italy. LTx patients were divided into two groups, according to disease severity evaluated by the Lung Allocation Score (LAS). To assess CAC, electrocardiogram (ECG) and respiration were recorded at rest for 10 min in supine position and for 10 min during active standing. Spectral analysis identified low and high frequencies (LF, sympathetic, and HF, vagal). Symbolic analysis identified three patterns, i.e., 0V% (sympathetic) and 2UV% and 2LV% (vagal). Compared to HCs, LTx patients showed higher markers of sympathetic modulation and lower markers of vagal modulation. However, more severely affected LTx patients, compared to less severely affected ones, showed an autonomic profile characterized by loss of sympathetic modulation and predominant vagal modulation. This pattern can be due to a loss of sympathetic rhythmic oscillation and a subsequent prevalent respiratory modulation of heart rate in severely affected patients.

1 January 2019 in Transplantation Proceedings
Verified
Journal Article
Closed access
IRilaria righi
ilaria righi
LMLetizia Corinna Morlacchi
Letizia Corinna Morlacchi
VRV. Rossetti
V. Rossetti
Paolo MendogniPaolo Mendogni
Paolo Mendogni
APA. Palleschi
A. Palleschi
MNM. Nosotti
M. Nosotti

1 January 2017 in Shanghai Chest
Verified
Journal Article
Closed access
PDF file
MNMario Nosotti
Mario Nosotti
IRilaria righi
ilaria righi
FDFrancesco Damarco
Francesco Damarco
LRLorenzo Rosso
Lorenzo Rosso
Tracheal sleeve pneumonectomy is a challenging surgical procedure for resection of cancers involving lung, lower trachea, carina and tracheobronchial angle. The most common indications are non-small cell lung cancers, bronchogenic carcinoma, carcinoid tumor, adenoid cystic carcinoma or inflammatory strictures. Other common indication is a positive resection margin after a standard pneumonectomy. This type of surgery is currently still infrequent, because of the complexity and the high risk of complications. The recent improvement of surgical techniques, different ventilation modalities and postoperative management has reduced dramatically the mortality and morbidity, especially in high volume centers. The careful selection of the patient and the correct preoperative staging is the central point for a successful operation. In this chapter we summarize “at a glance” the main topics of this kind of surgery, focusing on tips and tricks of the right patients selection, surgical techniques, postoperative management.

23 September 2020
Verified
Journal Article
Open access
Paolo MendogniPaolo Mendogni
Paolo Mendogni
EDElisa Daffrè
Elisa Daffrè
LRLorenzo Rosso
Lorenzo Rosso
Alessandro PalleschiAlessandro Palleschi
Alessandro Palleschi
IRilaria righi
ilaria righi
Davide TosiDavide Tosi
Davide Tosi
Lung microwave ablation (MWA) is considered an alternative treatment in high-risk patients, not suitable for surgery. The aim of our study is to compare MWA and pulmonary lobectomy in high-risk, lung cancer patients. This was a single-center, propensity score-weighted cohort study. All adult patients who underwent CT guided MWA for stage I NSCLC between June 2009-October 2014 were included in the study and were compared with a cohort of patients submitted to lung lobectomy in the same period of time. Outcomes were overall survival (OS) and disease-free survival (DFS). 32 patients underwent MWA, and 35 high-risk patients submitted to lung lobectomy in the same period were selected. Median follow-up time was 51.1 months (95% CI: 43.8-62.3). Overall survival was 43.8 (95% CI: 26.1-55) and 55.8 months (95% CI: 49.9-76.8) in the MWA group and Lobectomy group, respectively. Negative prognostic factors were MWA procedure (HR:2.25, 95% CI: 1.20-4.21, p= 0.0109) and nodule diameter (HR: 1.04, 95% CI: 1.01-1.07; p= 0.007) for OS, while MWA procedure (HR: 5.2; 95% CI: 2.1-12.8: p < 0.001), ECOG 3 (HR: 5.0; 95% CI: 1.6-15.6; p = 0.006) and nodule diameter (HR: 1.1; 95% CI: 1.0-1.1; p = 0.003) for DFS. Our study demonstrated a high percentage of local relapse in the MWA group but a comparable overall survival. Although lung lobectomy remains the gold standard treatment for stage I NSCLC, we can consider the MWA procedure as valid alternative local treatment in high-risk patients for stage I NSCLC. (www.actabiomedica.it)

1 April 2023 in Life
Verified
Journal Article
Open access
PDF file
GGGiorgia Grassi
Giorgia Grassi
ECElisa Cairoli
Elisa Cairoli
LGLucrezia Maria Silvana Gentile
Lucrezia Maria Silvana Gentile
Iacopo ChiodiniIacopo Chiodini
Iacopo Chiodini
MZMarta Zampogna
Marta Zampogna
CVCristina Eller Vainicher
Cristina Eller Vainicher
Background: During the first two years after lung transplantation (LTx), the incidence of fragility fractures (FX) is estimated to be 15–50% and it is lower in patients with cystic fibrosis (CF) as compared with other end-stage lung diseases (nCF). The aim of our study is to compare the skeletal outcomes, after the first 2 years post-LTx, in long-term survivors with CF and nCF. Materials and Methods: We evaluated the FX rate, the changes in bone mineral density (BMD) and trabecular bone score (TBS) in 68 patients (38 CF and 30 nCF) who underwent LTx in our center and with a follow-up after LTx longer than 5 years (7.3 ± 2.0 years). Results: After the second year post-LTx: (i) the FX rate was lower than during the first two years post-LTx (4.4 vs. 20.6%, p = 0.004), with no difference between CF and nCF patients (5.3 vs. 3.3%, p = 0.589); (ii) BMD at lumbar spine, femoral neck and total hip remained stable (−1.6 ± 1.0 vs. −1.4 ± 1.1, p = 0.431, −1.8 ± 0.9 vs. −1.9 ± 0.9, p = 0.683, −1.5 ± 0.9 vs. −1.4 ± 0.9, p = 0.678, respectively) as well as TBS (1.200 ± 0.124 vs. 1.199 ± 0.205, p = 0.166). Conclusions: After the second year post-LTx, the skeletal complications become less frequent and have similar incidence in patients with CF and nCF.